Infectious Diseases Unit, Sanz Medical Center, Laniado Hospital, Neytanya, Israel.
Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
PLoS One. 2019 Mar 28;14(3):e0214517. doi: 10.1371/journal.pone.0214517. eCollection 2019.
The epidemiology, clinical features and outcomes of hospitalized adult patients with Influenza A (FluA), Influenza B (FluB) and Respiratory Syncytial Virus (RSV) have not been thoroughly compared. The aim of this study was to describe the differences between these viruses during 3 winter seasons.
A retrospective observational study was conducted consisting of all the polymerase chain reaction (PCR)-based diagnoses of FluA, FluB and RSV among adults during 2015-2018, in one regional hospital. Epidemiology, clinical symptoms and outcome-related data were comparatively analyzed.
Between November 2015 and April 2018, 759 patients were diagnosed with FluA, FluB or RSV. Study cohort included 539 adult patients (306 FluA, 148 FluB and 85 RSV). FluB was predominant during the winter of 2017-18. RSV caused 15.7% of hospitalizations with diagnosed viral infection and in comparison to influenza, had distinct epidemiological, clinical features and outcomes, including older age (74.2 vs 66.2, p = 0.001) and higher rates of co-morbidities; complications including bacterial pneumonia (31 vs 18%, p = 0.02), mechanical ventilation (20 vs 7%, p = 0.001), and viral-related death (13 vs 6.6%, p = 0.04). FluA and FluB had similar epidemiology, clinical symptoms and outcomes, but vaccinated patients were less prone to be hospitalized with FluB as compared with FluA (3 vs 14%, p = 0.001). Paroxysmal atrial fibrillation and falls were common (8.7 and 8.5% respectively).
FluA and FluB had similar epidemiological, clinical features and contributed equally to hospitalization burden and complications. RSV had a major impact on hospitalizations, occurring among the more elderly and sick populations and causing significantly worse outcomes, when compared to influenza patients. Vaccination appeared as a protective factor against hospitalizations with FluB as compared with FluA.
成人甲型流感(FluA)、乙型流感(FluB)和呼吸道合胞病毒(RSV)住院患者的流行病学、临床特征和结局尚未得到充分比较。本研究旨在描述这三种病毒在三个冬季的差异。
这是一项回顾性观察研究,纳入了 2015 年至 2018 年期间一家地区医院基于聚合酶链反应(PCR)的所有成人 FluA、FluB 和 RSV 诊断病例。对流行病学、临床症状和结局相关数据进行了比较分析。
2015 年 11 月至 2018 年 4 月,共诊断出 759 例 FluA、FluB 或 RSV 感染患者。研究队列纳入了 539 例成年患者(306 例 FluA、148 例 FluB 和 85 例 RSV)。2017-18 年冬季以 FluB 为主。RSV 导致 15.7%的病毒性感染住院,与流感相比,具有明显的流行病学、临床特征和结局,包括年龄较大(74.2 岁比 66.2 岁,p=0.001)和更高的合并症发生率;并发症包括细菌性肺炎(31%比 18%,p=0.02)、机械通气(20%比 7%,p=0.001)和与病毒相关的死亡(13%比 6.6%,p=0.04)。FluA 和 FluB 具有相似的流行病学、临床症状和结局,但与 FluA 相比,接种疫苗的患者住院的可能性较小(3%比 14%,p=0.001)。阵发性心房颤动和跌倒较为常见(分别为 8.7%和 8.5%)。
FluA 和 FluB 具有相似的流行病学特征,对住院负担和并发症的贡献相当。RSV 对住院的影响较大,发生在年龄较大和病情较重的人群中,与流感患者相比,结局明显较差。与 FluA 相比,接种疫苗似乎是预防 FluB 住院的保护因素。